Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

CAR T-cell therapy for cancer leads to similar safety and cancer outcomes in patients with and without preexisting autoimmune ...

Scientists engineered T cells to protect instead of kill, potentially enabling targeted treatments for autoimmune disease and ...

CAR-T-cell therapy treated a girl with a rare childhood cancer, raising hopes for future recipients of the approach.

The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...

A revolutionary approach to immune therapy has emerged: engineered immune cells that protect healthy tissue without ...

Fibrosis is a pathological process characterized by excessive deposition of extracellular matrix (ECM) components, leading to tissue scarring and organ ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

Scientists at the Institute for Systems Biology (ISB) have uncovered key insights into how T cells – the body's frontline immune soldiers – respond to infections like COVID-19. These findings could ...

Scientists explore how the immune and nervous systems constantly communicate, influencing brain diseases, behavior, and ...

the immune system is not mistakenly attacking specific cells in the body. It does do this in autoimmune diseases. Therefore, healthcare professionals currently classify AD and other types of ...

Breakthrough research and investor enthusiasm prompted Cullinan Therapeutics to redirect one of its cancer programs toward ...